Literature DB >> 3293890

Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretions.

R A Stockley1, J Shaw, S L Hill, D Burnett.   

Abstract

1. Some bronchiectatic patients persistently expectorate purulent secretions containing many polymorphonuclear leucocytes (PMN) and bacteria, suggesting ineffective microbial clearing from the lung. We have therefore studied several aspects of PMN recruitment to the lung by chemotaxis. 2. Circulating PMN from patients with bronchiectasis show a variable chemotactic response to the synthetic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine. This is similar to the response of PMN from healthy controls and suggests that failure to clear microbial organisms is not due to defective chemotaxis as measured here. 3. Purulent sputum solphase demonstrates chemotactic activity against control PMN. This activity is greater (P less than 0.001) than that found with mucoid sputum solphase, which is consistent with the neutrophil content of the secretions in vivo. 4. Successful antibiotic therapy reduces the chemotactic activity of purulent sputum solphase from a median value of 183 (range 28-201) cells/high power field to 33.5 (range 0.7-64) cells/high power field (P less than 0.0025). This indicates that the chemotactic activity is largely associated with bacterial load.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293890     DOI: 10.1042/cs0740645

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  A hampered chemoattractant-induced cytoskeletal rearrangement in granulocytes of patients with unexplained severe chronic and relapsing infections of the upper and lower airways. In vitro restoration by G-CSF exposure.

Authors:  P M J Kalkman; W J Fokkens; H J de Wit; J P van de Merwe; H Hooijkaas; J M W van Haarst; H C Hoogsteden; H A Drexhage
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Effect of bacterial products on neutrophil migration in vitro.

Authors:  G Ras; R Wilson; H Todd; G Taylor; P Cole
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

3.  Inhibition of human neutrophil migration in vitro by low-molecular-mass products of nontypeable Haemophilus influenzae.

Authors:  D R Cundell; G W Taylor; K Kanthakumar; M Wilks; S Tabaqchali; E Dorey; J L Devalia; D E Roberts; R J Davies; R Wilson
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

Review 4.  Autoinflammatory disease in the lung.

Authors:  Thomas Scambler; Jonathan Holbrook; Sinisa Savic; Michael F McDermott; Daniel Peckham
Journal:  Immunology       Date:  2018-04-19       Impact factor: 7.397

5.  Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro.

Authors:  C G Llewellyn-Jones; S L Hill; R A Stockley
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

6.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.

Authors:  K Oishi; F Sonoda; S Kobayashi; A Iwagaki; T Nagatake; K Matsushima; K Matsumoto
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 7.  Understanding the role of neutrophils in chronic inflammatory airway disease.

Authors:  Alice E Jasper; William J McIver; Elizabeth Sapey; Georgia M Walton
Journal:  F1000Res       Date:  2019-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.